ASPIRIN AND DIPYRIDAMOLE (aspirin and extended-release dipyridamole) by Micro Labs is cyclooxygenase inhibitors [moa]. Approved for stroke in patients, completed ischemic stroke due to thrombosis, completed ischemic stroke due to thrombosis ( ). First approved in 2021.
Drug data last refreshed 14h ago
Cyclooxygenase Inhibitors
Nonsteroidal Anti-inflammatory Drug
Worked on ASPIRIN AND DIPYRIDAMOLE at Micro Labs? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.